Iron
In clinical developmentAlso known as Eisen, Elemental Iron, Fe, Fe - Iron+6 more
Eisen, Elemental Iron, Fe, Fe - Iron, Ferrum, Hierro, Iron, elemental, Iron, reduced, Reduced iron, fer.
Recent clinical, regulatory, research and industry developments relating to this drug.
Ferroptosis in neurological diseases: moving towards therapeutic intervention.
Restoring Iron Deficiency to Expand Blood Volume and Improve POTS
Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications.
Microbial siderophores for One Health.
The role of ferroptosis in Alzheimer's disease: Mechanisms and therapeutic potential (Review).
Effect of Lactoferrin Administration on Rhabdomyolysis-induced Heart and Kidney Injury in Rats
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Efficacy and Safety of Lactoferrin in Heart Failure Patients
Recent completions
Trials that read out recently, adding to the completed evidence base.
Effect of Lactoferrin Administration on Rhabdomyolysis-induced Heart and Kidney Injury in Rats
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences4
- Cell death & disease2
- Molecular psychiatry2
- Nutrients2
- Advances in nutrition (Bethesda, Md.)1
- Archives of toxicology1
- Bush AI2
- Chen X2
- Kang R2
- Lei P2
- Li J2
- Li Z2
- Liu J2
- Liu Y2
- Department of Neurology and State Key Laboratory of Biotherapy2
- School of Public Health2
- UT Southwestern Medical Center2
- Affiliated Qiqihar Hospital1
- Affiliated Zhongshan Hospital of Dalian University1
- Albert Einstein College of Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 9 of the same disease areas as Iron in the shared literature.
Studied across 7 of the same disease areas as Iron in the shared literature.
Studied across 5 of the same disease areas as Iron in the shared literature.
Studied across 8 of the same disease areas as Iron in the shared literature.
Studied across 6 of the same disease areas as Iron in the shared literature.
Studied across 5 of the same disease areas as Iron in the shared literature.
Studied across 6 of the same disease areas as Iron in the shared literature.
Studied across 6 of the same disease areas as Iron in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials